Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol of Herceptin Adjuvant With Reduced Exposure, a Randomised Comparison of 6 Months vs 12 Months in All Women Receiving Adjuvant Herceptin [PHARE]

NCT00381901 is registered in ClinicalTrials.gov with National Cancer Institute, France as lead sponsor.

NCT NCT00381901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00381901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol of Herceptin Adjuvant With Reduced Exposure, a Randomised Comparison of 6 Months vs 12 Months in All Women Receiving Adjuvant Herceptin [PHARE]
Lead sponsor
National Cancer Institute, France
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2006
Completion date
Not reported
Enrollment
3,400 (estimated)
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer